Andy Kidd, M.D., is the Chief Executive Officer of Tentarix Biotherapeutics. Based in Evanston, Illinois.
Andy Kidd, M.D., is the Chief Executive Officer of Tentarix Biotherapeutics. He previously served as President and CEO of Aptinyx Inc., a CNS-focused biotechnology company, where he helped take the company public and moved several programs into clinical development. Prior to Aptinyx, he held senior leadership positions at Baxter International and began his career at The Boston Consulting Group. He holds an M.D. from the University of Oxford and a B.A. from the University of Cambridge.
Full founder directory · Investor directory · Company funding database · Fundraising library